We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UVXY icon
4651
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$293M
$764K ﹤0.01%
6,489
+6,277
+2,961% +$917K
UFCS icon
4652
United Fire Group
UFCS
$1.4B
$760K ﹤0.01%
35,384
+10,584
+43% +$234K
TARS icon
4653
Tarsus Pharmaceuticals
TARS
$2.84B
$760K ﹤0.01%
27,973
-10,367
-27% -$349K
NORW icon
4654
Global X MSCI Norway ETF
NORW
$86.1M
$760K ﹤0.01%
29,617
+18,895
+176% +$486K
FTLS icon
4655
First Trust Long/Short Equity ETF
FTLS
$2.49B
$760K ﹤0.01%
12,139
-20,811
-63% -$1.27M
ADAM
4656
Adamas Trust
ADAM
$883M
$759K ﹤0.01%
130,016
-36,871
-22% -$236K
DEHP icon
4657
Dimensional Emerging Markets High Profitability ETF
DEHP
$444M
$758K ﹤0.01%
29,150
SOUN icon
4658
SoundHound AI
SOUN
$3.49B
$756K ﹤0.01%
191,278
-11,505
-6% -$53.3K
HWKN icon
4659
Hawkins
HWKN
$2.71B
$755K ﹤0.01%
8,300
-25,786
-76% -$2.11M
ZLAB icon
4660
Zai Lab
ZLAB
$2.62B
$754K ﹤0.01%
43,485
-39,298
-47% -$691K
LMB icon
4661
Limbach Holdings
LMB
$581M
$753K ﹤0.01%
13,228
-6,740
-34% -$333K
BRY
4662
DELISTED
Berry Corp
BRY
$752K ﹤0.01%
116,445
-156,978
-57% -$1.17M
TSEM icon
4663
Tower Semiconductor
TSEM
$28.5B
$751K ﹤0.01%
19,116
-578
-3% -$20.5K
QDEF icon
4664
FlexShares Quality Dividend Defensive Index Fund
QDEF
$562M
$751K ﹤0.01%
11,457
+56
+0.5% +$3.56K
COLL icon
4665
Collegium Pharmaceutical
COLL
$956M
$749K ﹤0.01%
23,273
-8,328
-26% -$289K
PDFS icon
4666
PDF Solutions
PDFS
$2.07B
$748K ﹤0.01%
20,568
-9,464
-32% -$316K
SBI
4667
Western Asset Intermediate Muni Fund
SBI
$108M
$748K ﹤0.01%
95,138
-3,006
-3% -$23.4K
BDN
4668
Brandywine Realty Trust
BDN
$554M
$747K ﹤0.01%
166,766
-122,091
-42% -$556K
PPL
4669
CALL
PPL Corp
PPL
$26.7B
$747K ﹤0.01%
27,000
-45,100
-63% -$1.27M
BLNK icon
4670
Blink Charging
BLNK
$87.9M
$745K ﹤0.01%
271,989
-71,229
-21% -$203K
SPE.PRC
4671
Special Opportunities Fund Inc 2.75% Series C Preferred Stock
SPE.PRC
$62.9M
$744K ﹤0.01%
31,999
-521
-2% -$12.1K
MPX
4672
DELISTED
Marine Products Corp
MPX
$744K ﹤0.01%
73,700
+63,981
+658% +$688K
PLOW icon
4673
Douglas Dynamics
PLOW
$1.02B
$744K ﹤0.01%
31,786
+4,419
+16% +$105K
PBW icon
4674
Invesco WilderHill Clean Energy ETF
PBW
$461M
$742K ﹤0.01%
36,816
+8,273
+29% +$178K
PNI
4675
PIMCO New York Municipal Income Fund II
PNI
$77.7M
$742K ﹤0.01%
100,102
-6,858
-6% -$50K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.